Literature DB >> 8489712

Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.

T C Thompson1, T L Timme, D Kadmon, S H Park, S Egawa, K Yoshida.   

Abstract

Using a mouse prostate reconstitution (MPR) model system, strain-specific responses to the ras and myc oncogenes were investigated. When ras + myc were introduced into both the mesenchymal and epithelial compartments of the urogenital sinus, poorly differentiated prostate cancer was produced at a high frequency (> 90%) in inbred C57BL/6 mice. In contrast, under similar conditions, inbred BALB/c MPRs formed benign prostatic hyperplasia that converted to cancer at a low frequency (< 10%). Restricting the oncogenes to the mesenchymal or epithelial compartments revealed that oncogene activities were more pronounced in the mesenchyme of C57BL/6 mice and resulted in elevated transforming growth factor-beta 1 expression along with a severe desmoplastic reaction. Heterologous MPRs composed of BALB/c mesenchyme and C57BL/6 epithelium or vice versa demonstrated that intrinsic properties of BALB/c mesenchyme can arrest the progression of ras + myc-initiated C57BL/6 epithelium from benign hyperplasia to malignant carcinoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489712     DOI: 10.1002/mc.2940070307

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  9 in total

1.  Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines.

Authors:  S J Hall; T C Thompson
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.

Authors:  Alexandra Giatromanolaki; Michael I Koukourakis; Anastasios Koutsopoulos; Savvas Mendrinos; Efthimios Sivridis
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

3.  Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.

Authors:  T L Timme; G Yang; L D Truong; D Kadmon; S H Park; T C Thompson
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 4.  A role for the androgen-receptor in clinically localized and advanced prostate cancer.

Authors:  James L Mohler
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-04       Impact factor: 4.690

5.  Prostate cancer in a transgenic mouse.

Authors:  N M Greenberg; F DeMayo; M J Finegold; D Medina; W D Tilley; J O Aspinall; G R Cunha; A A Donjacour; R J Matusik; J M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

6.  A novel method for somatic transgenesis of the mouse prostate using the Sleeping Beauty transposon system.

Authors:  Kimberly D P Hammer; James D Alsop; Rita A Buresh-Stiemke; Katsiaryna Frantskevich; Rita L Malinowski; Laura S Roethe; Ginny L Powers; Paul C Marker
Journal:  Prostate       Date:  2014-03-20       Impact factor: 4.104

7.  Genetic background influences murine prostate gene expression: implications for cancer phenotypes.

Authors:  Daniella Bianchi-Frias; Colin Pritchard; Brigham H Mecham; Ilsa M Coleman; Peter S Nelson
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

8.  The stroma-a key regulator in prostate function and malignancy.

Authors:  Christina Hägglöf; Anders Bergh
Journal:  Cancers (Basel)       Date:  2012-05-29       Impact factor: 6.639

9.  Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently.

Authors:  Inga Reigstad; Hilde Y H Smeland; Trude Skogstrand; Kristina Sortland; Marei Caroline Schmid; Rolf K Reed; Linda Stuhr
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.